Search

Your search keyword '"Viola, Francesco"' showing total 1,151 results

Search Constraints

Start Over You searched for: Author "Viola, Francesco" Remove constraint Author: "Viola, Francesco"
1,151 results on '"Viola, Francesco"'

Search Results

2. A revised gap-averaged Floquet analysis of Faraday waves in Hele-Shaw cells

5. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! Registry

6. Sub-harmonic parametric instability in nearly-brimful circular-cylinders: a weakly nonlinear analysis

8. A fast computational model for the electrophysiology of the whole human heart

10. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

11. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

14. A daily time-step hydrological-energy-biomass model to estimate green roof performances across Europe to support planning and policies

15. FSEI-GPU: GPU accelerated simulations of the fluid-structure-electrophysiology interaction in the left heart

16. Effects of stenotic aortic valve on the left heart hemodynamics: a fluid-structure-electrophysiology approach

17. Direct numerical simulation of flapping flags in grid-induced turbulence

18. Positive Law and Natural Law

24. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

30. La ética de los derechos

32. Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration

35. Suppression of von K\'arm\'an vortex streets past porous rectangular cylinders

37. Update on Retinal Vein Occlusion

42. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

43. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

44. Text Reading Speed in a Language with a Shallow Orthography Benefits Less from Comprehension as Reading Ability Matures

45. One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry

49. Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration.

Catalog

Books, media, physical & digital resources